We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PIPP
6876
CALL
DELISTED
Pine Island Acquisition Corp.
PIPP
$1.02M ﹤0.01%
103,200
+21,500
+26% +$212K
RFCI icon
6877
ALPS Dynamic Core Income ETF
RFCI
$15.4M
$1.02M ﹤0.01%
45,036
-2,140
-5% -$49K
WMS icon
6878
PUT
Advanced Drainage Systems
WMS
$10.9B
$1.02M ﹤0.01%
11,300
+5,400
+92% +$555K
UGL icon
6879
CALL
ProShares Ultra Gold
UGL
$790M
$1.02M ﹤0.01%
72,000
-15,200
-17% -$233K
MACA
6880
DELISTED
Moringa Acquisition Corp Class A Ordinary Shares
MACA
$1.02M ﹤0.01%
103,571
-7
-0% -$69
HOLD
6881
DELISTED
AdvisorShares North Square McKee Core Reserves ETF
HOLD
$1.02M ﹤0.01%
10,439
-383
-4% -$37.4K
EWGS
6882
DELISTED
iShares MSCI Germany Small-Cap ETF
EWGS
$1.02M ﹤0.01%
18,413
-336
-2% -$21.9K
EPZM
6883
DELISTED
Epizyme, Inc
EPZM
$1.02M ﹤0.01%
691,458
-3,512,608
-84% -$2.58M
EHC icon
6884
CALL
Encompass Health
EHC
$12B
$1.01M ﹤0.01%
22,752
+13,073
+135% +$671K
TTT icon
6885
ProShares UltraPro Short 20+ Year Treasury
TTT
$17.3M
$1.01M ﹤0.01%
17,573
-32,946
-65% -$1.84M
OSG
6886
CALL
Octave Specialty Group
OSG
$207M
$1.01M ﹤0.01%
89,300
-188,200
-68% -$1.79M
DIEM icon
6887
Franklin Emerging Market Core Dividend Tilt Index ETF
DIEM
$91.4M
$1.01M ﹤0.01%
42,388
+16,388
+63% +$427K
VMD icon
6888
Viemed Healthcare
VMD
$347M
$1.01M ﹤0.01%
187,967
+52,247
+38% +$282K
PNNT
6889
Pennant Park Investment Corp
PNNT
$240M
$1.01M ﹤0.01%
163,404
-14,303
-8% -$102K
PEGA icon
6890
CALL
Pegasystems
PEGA
$5.34B
$1.01M ﹤0.01%
42,200
-182,200
-81% -$5.45M
DHS icon
6891
WisdomTree US High Dividend Fund
DHS
$1.6B
$1.01M ﹤0.01%
12,251
+9,448
+337% +$824K
EDD
6892
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$381M
$1.01M ﹤0.01%
224,416
+195,660
+680% +$904K
EPI icon
6893
CALL
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$1.01M ﹤0.01%
34,000
+17,700
+109% +$603K
GATX icon
6894
PUT
GATX Corp
GATX
$6.3B
$1.01M ﹤0.01%
10,700
+3,400
+47% +$363K
LOB icon
6895
PUT
Live Oak Bancshares
LOB
$1.97B
$1.01M ﹤0.01%
29,700
-2,000
-6% -$82.7K
NVTA
6896
CALL
DELISTED
Invitae Corporation
NVTA
$1.01M ﹤0.01%
412,800
+105,500
+34% +$467K
AVYA
6897
PUT
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$1.01M ﹤0.01%
449,400
+210,200
+88% +$1.5M
AQB icon
6898
AquaBounty Technologies
AQB
$7.1M
$1.01M ﹤0.01%
29,426
+23,685
+413% +$723K
ATAI icon
6899
AtaiBeckley Inc
ATAI
$2.7B
$1M ﹤0.01%
275,674
+211,127
+327% +$863K
ESPR
6900
CALL
DELISTED
Esperion Therapeutics
ESPR
$1M ﹤0.01%
157,700
+30,700
+24% +$174K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.